Oral administration of rutoside can ameliorate inflammatory bowel disease in rats
References (26)
Biochem Pharmacol
(1983)- et al.
Biochem Pharmacol
(1990) - et al.
Gastroenterology
(1989) - et al.
Gastroenterolgy
(1984) - et al.
J Biol Chem
(1946) Anal Biochem
(1976)Methods Enzymol
(1985)- et al.
Gastroenterology
(1992) - et al.
Gastroenterolgy
(1989) - et al.
Curr Opin Gastroenterol
(1993)
J Pharm Exp Ther
(1996)
Cited by (99)
Comprehensive and critical view on the anti-inflammatory and immunomodulatory role of natural phenolic antioxidants
2024, European Journal of Medicinal ChemistryFlavonoids nanostructures promising therapeutic efficiencies in colorectal cancer
2023, International Journal of Biological MacromoleculesInflammatory auto-immune diseases of the intestine and their management by natural bioactive compounds
2022, Biomedicine and PharmacotherapyPolyphenols in the Prevention of Ulcerative Colitis: A Revisit. A Revisit.
2019, Dietary Interventions in Gastrointestinal Diseases: Foods, Nutrients, and Dietary SupplementsSmall-Molecule Drugs for the Treatment of Inflammatory Bowel Disease
2017, Comprehensive Medicinal Chemistry IIIProtective effect of isoquercitrin against acute dextran sulfate sodium-induced rat colitis depends on the severity of tissue damage
2016, Pharmacological ReportsCitation Excerpt :Isoquercitrin was tested at the daily doses of 1 and 10 mg/kg/day. These doses were selected on the basis of in vivo studies showing the anti-inflammatory activity of related flavonoids including quercetin [14] and quercetin glycosides, quercitrin (quercetin-3-O-α-l-rhamnopyranoside) [15,14] and rutin (quercetin-3-O-β-rutinoside) [16,17]. In our study, rats were daily administered isoquercitrin by oral gavage for 2 weeks, and during the last 7 days the intestinal inflammation was induced by oral administration of 5% DSS in drinking water.
Copyright © 1998 Published by Elsevier Inc.